ArticleActa pharmaceutica Sinica. B2023

Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor.

Shiyang Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.